The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Americas White Paper

3 Dec 2020 07:00

RNS Number : 3397H
Quadrise Fuels International PLC
03 December 2020
 

3 December 2020

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Publication of Americas White Paper

 

Quadrise Fuels International, supplier of MSAR® emulsion technology and fuels, a low-cost, cleaner alternative to heavy fuel oil, is pleased to announce the publication of a White Paper detailing the potential economic and environmental benefits of the implementation of MSAR® technology in the Americas. The paper is entitled "A clean solution to the Americas' heavy fuel oil problem" and is available at: https://www.quadrisefuels.com/americas-white-paper.

A Spanish-language version of the report is also available on the QFI website at the link above. The Company website, including animated video introductions, is also now available in Spanish (https://www.quadrisefuels.com/es).

Americas White Paper Highlights:

· Quadrise's MSAR® technology enables production of a proprietary oil-in-water emulsion fuel oil - MSAR®, that reduces energy costs for consumers and improves refinery profitability and yields.

· Offers the most cost effective and cleanest refinery residue upgrading technology.

· Delivers significant environmental benefits with a 30% reduction in NOx emissions and 50% lower ash emissions, with further potential to reduce CO2 by 20% (same as LNG).

· Implementation of MSAR® in refineries and power generation facilities in key regions such as Ecuador and Mexico can deliver cost savings of ~US$100 million per year per refinery to governments, whilst also benefiting the population and environment through lower emissions.

· Oil-in-water emulsions have been used worldwide, with 100,000 bpd commercial supply experience and over 60 million tons consumed in power generation and industrial facilities. The latest generation, MSAR®, is now on the verge of being implemented in the Americas, Africa, Europe and the Middle East.

· Strong synergies with metals recovery from ash - including vanadium, a critical component for the manufacture and deployment of renewable energy storage batteries.

· With over ten years of working in the region, Quadrise is now poised to progress regional commercial implementation.

 

Mike Kirk, Chairman, commented:

 

"Following the publication of our Middle East White Paper, we are pleased to highlight the economic and environmental benefits of MSAR® in the Americas, another market where we see significant potential for our technology.

The nations of the Americas are on the cusp of the fast-growing energy transition seen in other parts of the world. However, oil will continue to be a major source of energy production in the region for a significant period.

By adopting technologies such as MSAR®, that can be implemented rapidly and deliver significant financial benefits and improved environmental benefits, a sustainable pathway to renewables for the region can be created".

 

Enquiries:

 

Quadrise Fuels International Plc +44 (0)20 7031 7321

Mike Kirk, Chairman

Jason Miles, Chief Executive Officer

 

Public & Investor Relations

FTI Consulting +44 (0)20 3727 1000

Ben Brewerton

Ntobeko Chidavaenzi

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQLLFBBLLEFBK
Date   Source Headline
2nd Feb 20217:00 amRNSUpdate re Morocco and Greenfield Energy Projects
1st Feb 20217:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 20217:00 amRNSIssue of Equity
21st Jan 20217:00 amRNSJoint Development Agreement - MSC Shipmanagement
6th Jan 20217:00 amRNSIssue of Equity
4th Jan 20217:00 amRNSChange of Registered Office
18th Dec 202011:46 amRNSUpdate re Greenfield MSAR Trial
18th Dec 20207:00 amRNSbioMSAR Testing Update & Collaboration Agreement
15th Dec 20207:00 amRNSLaunch of bioMSAR
3rd Dec 20207:00 amRNSPublication of Americas White Paper
27th Nov 202012:13 pmRNSResult of AGM
27th Nov 20207:00 amRNSAGM Statement
24th Nov 20208:00 amEQSQuadrise Fuels International (QFI): The clean solution to a global problem
2nd Nov 20205:23 pmRNSPosting of Annual Report and Notice of AGM
26th Oct 20207:00 amRNSMorocco Update
5th Oct 20207:00 amRNSFinal Results, Investor Presentation & AGM Notice
7th Sep 20205:56 pmRNSIssue of Equity
7th Sep 20207:00 amRNSNotice of Results, Update and Investor Event
24th Aug 20207:00 amRNSIssue of Share Options
20th Aug 20207:00 amRNSIssue of Equity
18th Aug 20207:22 amRNSGreenfield MSAR Commercial Trial Agreement
17th Aug 20207:00 amRNSPublication of White Paper
17th Jul 20203:59 pmRNSInvestor Presentation
30th Jun 20209:18 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
23rd Jun 20207:00 amRNSIssue of Equity
18th Jun 20207:00 amRNSStatement re MSAR Licensing and Upstream Trial
17th Jun 20201:47 pmRNSStatement re MSAR Licensing
2nd Jun 20207:00 amRNSInvestor Presentation
1st May 20207:00 amRNSFurther Statement re Covid-19 and Update
16th Apr 20202:21 pmRNSIssue of Equity
15th Apr 20207:00 amRNSDirectorate Change
30th Mar 20204:13 pmRNSNew Website
30th Mar 202011:02 amRNSHalf-year Report - Replacement
30th Mar 20207:00 amRNSHalf-year Report
24th Mar 202010:13 amRNSIssue of Equity
16th Mar 20207:00 amRNSStatement re Covid-19 and Morocco Pilot Trial
5th Mar 20209:10 amRNSUpdate on Morocco Pilot Trial
17th Feb 20207:00 amRNSNotice of Interim Results and Business Update
30th Jan 20207:00 amRNSAppointment of New Auditors
15th Jan 20207:00 amRNSDirectorate Changes
16th Dec 20198:38 amRNSDirectorate Change
29th Nov 20194:42 pmRNSResult of AGM
29th Nov 20197:05 amRNSIssue of Warrants
29th Nov 20197:00 amRNSAGM Update
29th Nov 20197:00 amRNSMaterial Transfer & Cooperation Agreement
6th Nov 20195:03 pmRNSPosting of Annual Report and Notice of AGM
10th Oct 20195:42 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSNew three-year Exclusive Agreement with Nouryon

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.